FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway

Pre- and post-translational regulation of osteopontin in cancer

(2011) Pieter H. Anborgh et al.   Journal of Cell Communication and Signaling

Fibulin-3 is associated with tumour progression and a poor prognosis in nasopharyngeal carcinomas and inhibits cell migration and invasion via suppressed AKT activity

(2010) Chung-Feng Hwang et al.   JOURNAL OF PATHOLOGY

Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients

(2009) Zi-Ming Du et al.   INTERNATIONAL JOURNAL OF CANCER

Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity

(2009) C-H Chen et al.   ONCOGENE

VEGFA Upregulates FLJ10540 and Modulates Migration and Invasion of Lung Cancer via PI3K/AKT Pathway

(2009) Chang-Han Chen et al.   PLoS One

Post-translational modification and proteolytic processing of urinary osteopontin

(2008) Brian Christensen et al.   BIOCHEMICAL JOURNAL

Overexpression of β2-microglobulin is associated with poor survival in patients with oral cavity squamous cell carcinoma and contributes to oral cancer cell migration and invasion

(2008) C-H Chen et al.   BRITISH JOURNAL OF CANCER

Nasopharyngeal carcinoma

(2008) V.F.H. Chong et al.   EUROPEAN JOURNAL OF RADIOLOGY

Hepatocyte growth factor enhances proteolysis and invasiveness of human nasopharyngeal cancer cells through activation of PI3K and JNK

(2008) Hong Yan Zhou et al.   FEBS LETTERS

Nasopharyngeal carcinoma—Review of the molecular mechanisms of tumorigenesis

(2008) Josephine Chou et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Clinical significance of osteopontin expression in cervical cancer

(2008) HanByoul Cho et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY